{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T05:06:50Z","timestamp":1696482410220},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[1984,1]]},"DOI":"10.1007\/bf02134259","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T22:46:27Z","timestamp":1126737987000},"page":"167-170","source":"Crossref","is-referenced-by-count":17,"title":["\u03b2-Adrenergic receptor subtypes in iris-ciliary body of rabbits"],"prefix":"10.1007","volume":"221","author":[{"given":"C. J.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. N.","family":"Share","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02134259_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0773.1967.tb02994.x","volume":"25","author":"B Ablad","year":"1967","unstructured":"Ablad B, Brogard M, Ek L (1967) Pharmacological properties of H56\/28 \u2014 a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol 25: 9\u201340","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF02134259_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0024-3205(73)90368-8","volume":"12","author":"B Ablad","year":"1973","unstructured":"Ablad B, Carlsson E, Ek L (1973) Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci 12: 107\u2013119","journal-title":"Life Sci"},{"key":"BF02134259_CR3","doi-asserted-by":"crossref","unstructured":"Baldwin JJ, Denny GH, Gross DM, Hirschmann R, Freedman MB, Ponticello GS, Sweet CS (1983) Beta1-selective adrenoceptor antagonists: examples of the 2-[4-(3-substituted-amino-2-hydroxypropoxy)phenyl] imidazole class. J Med Chem (in press)","DOI":"10.1021\/jm00361a004"},{"key":"BF02134259_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0014-4835(80)80031-5","volume":"31","author":"G Bhargava","year":"1980","unstructured":"Bhargava G, Makman MH, Katzman R (1980) Distribution of beta-adrenergic receptors and isoproterenol-stimulated cyclic AMP formation in monkey iris and ciliary body. Exp Eye Res 31: 471\u2013477","journal-title":"Exp Eye Res"},{"key":"BF02134259_CR5","first-page":"292P","volume":"69","author":"A Bilski","year":"1980","unstructured":"Bilski A, Dorries S, Fitzgerald JD, Jessup R, Tucker H, Wale J (1980) ICI 118,551, a potent beta2-adrenoceptor antagonist. Br J Pharmacol 69: 292P-293P","journal-title":"Br J Pharmacol"},{"key":"BF02134259_CR6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(64)91275-9","volume":"1","author":"JW Black","year":"1964","unstructured":"Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC (1964) A new adrenergic beta-receptor antagonist. Lancet 1: 1080\u20131081","journal-title":"Lancet"},{"key":"BF02134259_CR7","first-page":"445P","volume":"66","author":"JP Boudot","year":"1979","unstructured":"Boudot JP, Cavero I, Fenard S, Lefevre-Borg F, Manoury P, Roach AG (1979) Preliminary studies on SL 75212, a new potent cardioselective betaadrenoceptor antagonist. Br J Pharmacol 66: 445P","journal-title":"Br J Pharmacol"},{"key":"BF02134259_CR8","first-page":"203","volume":"19","author":"BB Bromberg","year":"1980","unstructured":"Bromberg BB, Gregory DS, Sears ML (1980) Beta-adrenergic receptors in ciliary processes of the rabbit. Invest Ophthalmol Vis Sci 19: 203\u2013207","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF02134259_CR9","first-page":"568","volume":"12","author":"DB Bylund","year":"1976","unstructured":"Bylund DB, Snyder SH (1976) Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12: 568\u2013580","journal-title":"Mol Pharmacol"},{"key":"BF02134259_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-4835(81)90034-8","volume":"32","author":"J Cepelik","year":"1981","unstructured":"Cepelik J, Cernohorsky M (1981) The effects of adrenergic agonists and antagonists on the adenylate cyclase in albino rabbit ciliary processes. Exp Eye Res 32: 291\u2013299","journal-title":"Exp Eye Res"},{"key":"BF02134259_CR11","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y-C Cheng","year":"1973","unstructured":"Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"BF02134259_CR12","first-page":"69","volume":"20","author":"BK Colasanti","year":"1981","unstructured":"Colasanti BK, Trotter RR (1981) Effects of selective beta1 and beta2-adrenoceptor agonists and antagonists on intraocular pressure in the cat. Invest Ophthalmol Vis Sci 20: 69\u201376","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF02134259_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-4835(79)90050-2","volume":"29","author":"Z Dafna","year":"1979","unstructured":"Dafna Z, Lahav M, Melamed E (1979) Localization of beta-adrenoceptors in the anterior segment of the albino rabbit eye using a fluorescent analog of propranolol. Exp Eye Res 29: 327\u2013330","journal-title":"Exp Eye Res"},{"key":"BF02134259_CR14","first-page":"131","volume-title":"Vascular neuroeffector mechanisms, Second Int Symp, Odense","author":"RF Furchgott","year":"1976","unstructured":"Furchgott RF (1976) Postsynaptic adrenergic receptor mechanisms in vascular smooth muscle. In: Vascular neuroeffector mechanisms, Second Int Symp, Odense. Karger, Basel, pp 131\u2013142"},{"key":"BF02134259_CR15","first-page":"251","volume":"213","author":"RA Hall","year":"1975","unstructured":"Hall RA, Robson RD, Share NN (1975) Timolol maleate, a new beta-adrenergic receptor blocking agent. Arch Int Pharmacodyn Ther 213: 251\u2013263","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF02134259_CR16","first-page":"329","volume":"199","author":"HH Harms","year":"1976","unstructured":"Harms HH (1976) Isoproterenol antagonism of cardioselective beta-adrenergic receptor blocking agents: a comparative study of human and guinea pig cardiac and bronchial beta-adrenergic receptors. J Pharmacol Exp Therap 199: 329\u2013335","journal-title":"J Pharmacol Exp Therap"},{"key":"BF02134259_CR17","first-page":"503","volume":"212","author":"A Hedberg","year":"1980","unstructured":"Hedberg A, Minneman KP, Molinoff PB (1980) Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea pig heart. J Pharmacol Exp Therap 212: 503\u2013508","journal-title":"J Pharmacol Exp Therap"},{"key":"BF02134259_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1476-5381.1977.tb07508.x","volume":"60","author":"JL Imbs","year":"1977","unstructured":"Imbs JL, Miesch F, Schwartz J, Velly J (1977) A potent new beta2- adrenoceptor blocking agent. Br J Pharmacol 60: 357\u2013362","journal-title":"Br J Pharmacol"},{"key":"BF02134259_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265\u2013275","journal-title":"J Biol Chem"},{"key":"BF02134259_CR20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.2042-7158.1978.tb13237.x","volume":"30","author":"D MacKay","year":"1978","unstructured":"MacKay D (1978) How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? J Pharm Pharmacol 30: 312\u2013313","journal-title":"J Pharm Pharmacol"},{"key":"BF02134259_CR21","first-page":"502","volume":"211","author":"KP Minneman","year":"1979","unstructured":"Minneman KP, Hedberg A, Molinoff PB (1979) Comparison of beta-adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Therap 211: 502\u2013508","journal-title":"J Pharmacol Exp Therap"},{"key":"BF02134259_CR22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0006-2952(80)90424-4","volume":"29","author":"KP Minneman","year":"1980","unstructured":"Minneman KP, Molinoff PB (1980) Classification and quantitation of betaadrenergic receptor subtypes. Biochem Pharmacol 29: 1317\u20131323","journal-title":"Biochem Pharmacol"},{"key":"BF02134259_CR23","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1073\/pnas.77.12.7420","volume":"77","author":"JA Nathanson","year":"1980","unstructured":"Nathanson JA (1980) Adrenergic regulation of intraocular pressure: identification of beta2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium. Proc Natl Acad Sci USA 77: 7420\u20137424","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02134259_CR24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1476-5381.1981.tb16776.x","volume":"73","author":"JA Nathanson","year":"1981","unstructured":"Nathanson JA (1981) Effects of a potent and specific beta2-adrenoceptor antagonist on intraocular pressure. Br J Pharmacol 73: 97\u2013100","journal-title":"Br J Pharmacol"},{"key":"BF02134259_CR25","first-page":"1118","volume":"16","author":"AH Neufeld","year":"1977","unstructured":"Neufeld AH, Page ED (1977) In vitro determination of the ability of drugs to bind to adrenergic receptors. Invest Ophthalmol Vis Sci 16: 1118\u20131124","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF02134259_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.2042-7158.1981.tb13762.x","volume":"33","author":"SR O'Donnell","year":"1981","unstructured":"O'Donnell SR, Walduck K (1981) How beta2-selective in the adrenoceptor antagonist drug. IPS 339? J Pharm Pharmacol 33: 223\u2013225","journal-title":"J Pharm Pharmacol"},{"key":"BF02134259_CR27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.2042-7158.1979.tb13629.x","volume":"31","author":"SR O'Donnell","year":"1979","unstructured":"O'Donnell SR, Wanstall JC (1979) pA2 values of selective beta- adrenoceptor antagonists on isolated atria demonstrate a species difference in the beta-adrenoceptor populations mediating chronotropic responses in cat and guinea pig. J Pharm Pharmacol 31: 686\u2013690","journal-title":"J Pharm Pharmacol"},{"key":"BF02134259_CR28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0024-3205(80)90008-9","volume":"27","author":"SR O'Donnell","year":"1980","unstructured":"O'Donnell SR, Wanstall JC (1980) Evidence that ICI 118,551 is a potent, highly beta2-selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissues. Life Sci 27: 671\u2013677","journal-title":"Life Sci"},{"key":"BF02134259_CR29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0031-6989(79)80025-9","volume":"11","author":"C Omini","year":"1979","unstructured":"Omini C, Somerville AR, Folco GC, Rossoni G, Puglisi L (1979) Interaction between beta1 and beta2 adrenoceptors in the isolated guinea pig trachea. Pharmacol Res Comm 11: 529\u2013535","journal-title":"Pharmacol Res Comm"},{"key":"BF02134259_CR30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-2952(78)90424-0","volume":"27","author":"ED Page","year":"1978","unstructured":"Page ED, Neufeld AH (1978) Characterization of alpha and beta- adrenergic receptors in membranes prepared from the rabbit iris before and after development of supersensitivity. Biochem Pharmacol 27: 953\u2013958","journal-title":"Biochem Pharmacol"},{"key":"BF02134259_CR31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0014-4835(78)90029-5","volume":"27","author":"DE Potter","year":"1978","unstructured":"Potter DE, Rowland JM (1978) Adrenergic drugs and intraocular pressure: effects of selective beta-adrenergic agonists. Exp Eye Res 27: 615\u2013625","journal-title":"Exp Eye Res"},{"key":"BF02134259_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(68)90002-2","volume":"4","author":"C Raper","year":"1968","unstructured":"Raper C, Wale J (1968) Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias. Eur J Pharmacol 4: 1\u201312","journal-title":"Eur J Pharmacol"},{"key":"BF02134259_CR33","first-page":"435","volume-title":"Catecholamines: basic and clinical frontiers","author":"J Zaagsma","year":"1978","unstructured":"Zaagsma J, Oudhof R, van der Heijden PJMC, Plantje JF (1978) In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon Press, New York, pp 435\u2013437"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02134259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02134259\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02134259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T13:34:38Z","timestamp":1626528878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02134259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,1]]}},"alternative-id":["BF02134259"],"URL":"https:\/\/doi.org\/10.1007\/bf02134259","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,1]]}}}